Challenges in Prostate Cancer (eBook)
296 Seiten
John Wiley & Sons (Verlag)
978-1-4051-7177-9 (ISBN)
second most common cancer in men, in many countries. Therefore it
is increasingly important that those faced with difficult clinical
questions make the right decisions. Since the first volume was
published in 2000, many debates persist but new controversies have
also emerged, reflected in the chapters of this new volume. New
authors have been recruited to give their insight into newer areas
of this controversial topic.
Challenges in prostate cancer provides a series of
state-of-the-art review articles, each of which addresses and
answers a contentious question. It includes chapters on medical and
surgical management of all stages of prostate cancer, clinical
investigation, epidemiology, clinical trials and basic scientific
research and covers issues such as the genetic basis of cancer,
clinical economics and influence.
The authors have used their expertise to distil the available
evidence into practical advice to be used by busy urologists in
their day-to-day practice. And as well as being an overview of
current practice many chapters attempt to give insights into the
future direction of prostate cancer research and clinical
management.
Winsor Bowsher (deceased), Department of Urology, St. Joseph's Hospital, Newport Adam Carter, Department of Urology, Royal Gwent Hospital, Newport
List of contributors.
Part 1: Biological and Scientific Aspects.
1 Tim Lane, Jon Strefford and Tim Oliver.
An Update on Biotechnology in the Assessment of Prostate
Cancer.
2 Ludger Barthelmes and Christopher A. Gateley.
What Can We Learn From Breast Cancer?.
3 Bernhard Brehmer, Antonio Smakris and Gerhard
Jakse.
New Serum Markers for Prostate Cancer.
4 Kenichiro Ishii and Simon Hayward.
The History of Tissue Recombination Technology: Current and
Future Research.
5 Malcolm Mason and John Staffurth.
Why We Cannot Use the Results of Non-Randomised Trials to Inform
Us About Treatment for Early Prostate Cancer?.
Part 2: Diagnosis and Evaluation.
6 Bob Djavan, Michael Dobrovits and Michael
Marberger.
Equivocal PSAResults and Free Total PSARatio.
7 Murali Varma And David Griffiths .
Equivocal Prostate Needle Biopsies.
8 Richard Clements.
Prostate Biopsy: How Many Cores and Where From?.
9 Gail Beese and Christopher Edmunds.
Counselling Patients With Early Prostate Cancer.
10 Owen Niall and Jamie Kearsley.
The Role of Pelvic Node Dissection in Prostate Cancer.
Part 3: Initial Treatment Policies.
11 Mark Wright.
Laparoscopic Radical Prostatectomy.
12 A. Goyal and W. Bowsher.
Endocrine Therapy for Prostate Cancer: the Latest.
13 Stijn De Vries, Christopher Bangma and Fritz
Schröder.
The Role of Conservative Policies in the Treatment of Prostate
Cancer.
14 Gary Deng and Barrie Cassileth.
Complementary and Alternative Therapies for Prostate Cancer.
Part 4: Monitoring Progress and SecondaryTreatment.
15 Amir Kaisary.
Radical Prostatectomy After Radical Radiotherapy.
16 Paul Jones and Neil Fenn.
Treatment of Renal Impairment Secondary to Locally Advanced
Prostate Cancer.
17 Robert P. Myers, R. Houston Thompson, Stephen M. Schatz
and Michael L. Blute.
Open Radical Prostatectomy: How Can Intra-operative,
Peri-operative and Post-operative Complications Be Prevented?.
18 Leslie Moffat.
Documenting Prostate Cancer: Epidemiology and Treatment.
19 Steven Oliver, Rhidian Hurle and Owen Hughes.
Trends in Prostate Cancer Incidence and Mortality.
20 Jason Lester and E M Mahudson.
Chemotherapy in Prostate Cancer.
Index.
Colour plates
"Currently there are more questions than answers in prostate cancer
and the authors certainly could not have been expected to provide
all the solutions for these many difficult issues. They have set
out the problems clearly, however, and by doing so set a challenge
for all of us in the urological community to provide the evidence
based resolution to these many thorny issues by carefully
constructed, long-term randomised files."
British Journal of Urology
"...contains useful information and is a helpful resource for
understanding many of the controversies in this area."
The Lancet
Erscheint lt. Verlag | 24.4.2008 |
---|---|
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie | |
Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung | |
Schlagworte | Medical Science • Medizin • Oncology & Radiotherapy • Onkologie u. Strahlentherapie • Urologie • Urology |
ISBN-10 | 1-4051-7177-4 / 1405171774 |
ISBN-13 | 978-1-4051-7177-9 / 9781405171779 |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |
Größe: 1,6 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich